{
 "as_of": "2026-11-06",
 "cmr": "se-cm-kg/XSTO/SE0015244520",
 "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.",
 "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# BioInvent International AB (Nasdaq Stockholm: SE0015244520) — research page\n\nAs of 2026-11-06 · se-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is BioInvent International AB, listed on Nasdaq Stockholm under the ticker SE0015244520 with ISIN SE0015244520 and LEI 549300E7QRHEF2IJUY10. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 39 filings in the twelve months to 2026-11-06, on 32 filing days. The median gap between filing days is 8 days. The latest filing is 1 day before the record date, and its date is 2026-11-05, of type Inside information. The exchange median gap between filing days is 9.5 days, the exchange median is 30.0 filings and the exchange median latency is 7.0 days, across 398 issuers on Nasdaq Stockholm. The sector comparison is not on the record.\n\n## Auditor\n\nThe auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.\n\n## Events and halts\n\nThe record carries no listing, delisting, name change, domicile change or segment move lines, because the lifecycle type map for this market is not yet on the register. The issuer is listed, not halted.\n\n## Orderability\n\nThe outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nThe issuer's investor-relations page names 4 research houses: Pareto Securities, Zurich; Kempen, Amsterdam; Redeye, Stockholm; and DNB Carnegie, Stockholm.\n\n## Open research\n\nNo openly published research notes were found on the record.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is given for the market, and the live record began on no date given.\n\n## Sources\n\n7 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://firds.esma.europa.eu/firds/ (identity.exchange)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://mcp.se-cm-kg.ai/events/XSTO/SE0015244520 (the disclosure lines)\n- https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation (the halt flag)\n- https://se.eu-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://www.bioinvent.com/en/investors/analysts (coverage)\n- https://mcp.se-cm-kg.ai/record/XSTO/SE0015244520 (the record)\n",
 "market": "SE",
 "node": "se-cm-kg",
 "numbers": {
  "as_of_depth": {
   "issuer_years_sealed": [],
   "live_record_began": null,
   "node_history_from": null,
   "node_years_sealed": [],
   "note": "the SE vintage is not sealed; the record is the live record as of 2026-11-06",
   "record_version": 1,
   "sealed": false
  },
  "auditor": {
   "auditor": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_firm_id": {
    "market": "SE",
    "state": "not_on_record"
   },
   "auditor_location": {
    "market": "SE",
    "state": "not_on_record"
   },
   "changes": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "cmr": "se-cm-kg/XSTO/SE0015244520",
  "coverage": {
   "count": 4,
   "houses": [
    {
     "analyst": "Chien-Hsun Lee",
     "house": "Pareto Securities, Zurich",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.bioinvent.com/en/investors/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Sebastiaan van der Schoot",
     "house": "Kempen, Amsterdam",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.bioinvent.com/en/investors/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Richard Ramanius",
     "house": "Redeye, Stockholm",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.bioinvent.com/en/investors/analysts",
     "state": "sourced"
    },
    {
     "analyst": "Arvid Necander",
     "house": "DNB Carnegie, Stockholm",
     "read_by": "issuer IR page, fetched by this rail; each house name read on the page",
     "read_date": "2026-11-12",
     "source": "https://www.bioinvent.com/en/investors/analysts",
     "state": "sourced"
    }
   ],
   "pages_checked": [
    {
     "page": "https://www.bioinvent.com/en/investors/analysts",
     "result": "read: 4 of 10 named houses found on the page"
    }
   ],
   "read_by": "Perplexity sonar (search) · page read by this rail",
   "read_date": "2026-11-12",
   "since": "not stated on the page read",
   "state": "found"
  },
  "disclosure": {
   "against": {
    "exchange": {
     "issuers": 398,
     "median_cadence_gap_days": 9.5,
     "median_filings": 30,
     "median_latency_days": 7,
     "name": "Nasdaq Stockholm"
    },
    "sector": {
     "market": "SE",
     "state": "not_on_record"
    }
   },
   "by_type": {
    "Annual Financial Report": 1,
    "Changes board/management/auditors": 1,
    "Decisions of general meeting": 1,
    "Financial Statement Release": 1,
    "Half Year financial report": 1,
    "Inside information": 7,
    "Interim report (Q1 and Q3)": 2,
    "Investor News": 22,
    "Notice to general meeting": 3
   },
   "cadence_median_gap_days": 8,
   "filing_days": 32,
   "filings": 39,
   "latency_days": 1,
   "latest": [
    {
     "category": "Inside information",
     "date": "2026-11-05",
     "source": "https://view.news.eu.nasdaq.com/view?id=b944b37c796fe6589286e0fe73134fc4e&lang=en&src=listed",
     "title": "BioInvent announces final terms for the Rights Issue of approximately SEK 430 million and informs that the Issue is fully guaranteed by additional top guarantee undertakings",
     "type": "Inside information"
    },
    {
     "category": "Notice to general meeting",
     "date": "2026-10-30",
     "source": "https://view.news.eu.nasdaq.com/view?id=b496efcb9c3b30711ebc61dcc8f695166&lang=en&src=listed",
     "title": "Supplement: Notice to Extraordinary General Meeting in BioInvent International AB",
     "type": "Notice to general meeting"
    },
    {
     "category": "Notice to general meeting",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=bf11a31c0dd9484aade510c121112d3d5&lang=en&src=listed",
     "title": "Notice to Extraordinary General Meeting in BioInvent International AB",
     "type": "Notice to general meeting"
    },
    {
     "category": "Interim report (Q1 and Q3)",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b86a2c80064bd2c7c0efab3928730ca03&lang=en&src=listed",
     "title": "BioInvent International AB: Interim report January - September, 2026",
     "type": "Interim report (Q1 and Q3)"
    },
    {
     "category": "Inside information",
     "date": "2026-10-28",
     "source": "https://view.news.eu.nasdaq.com/view?id=b59a13d30423aef907d0b1f1c3b2682c5&lang=en&src=listed",
     "title": "BioInvent resolves on a rights issue of approximately SEK 430 million subject to approval by an extraordinary general meeting and earlier publication of interim report January - September 2026",
     "type": "Inside information"
    }
   ],
   "latest_filing_date": "2026-11-05",
   "read": "the node's event lines (list_events_since), as get_filings serves them",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0015244520",
   "window": {
    "from": "2025-11-06",
    "to": "2026-11-06"
   }
  },
  "identity": {
   "exchange": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "Nasdaq Stockholm"
   },
   "isin": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0015244520"
   },
   "jurisdiction": {
    "market": "SE",
    "state": "not_on_record"
   },
   "lei": {
    "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN",
    "read_date": "2026-11-09",
    "read_date_basis": "the field",
    "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN SE0015244520)",
    "state": "sourced",
    "value": "549300E7QRHEF2IJUY10"
   },
   "name": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "BioInvent International AB"
   },
   "sector": {
    "market": "SE",
    "state": "not_on_record"
   },
   "security_type": {
    "market": "SE",
    "state": "not_on_record"
   },
   "segment": {
    "market": "SE",
    "state": "not_on_record"
   },
   "ticker": {
    "read_by": "allooloo-cm-kg/eu-sources/se roster.py",
    "read_date": "2026-11-06",
    "read_date_basis": "the record version as_of",
    "source": "https://firds.esma.europa.eu/firds/ (ESMA FIRDS FULINS_E 2026-11-07: FULINS_E_20261107_01of02.zip, FULINS_E_20261107_02of02.zip)",
    "state": "sourced",
    "value": "SE0015244520"
   },
   "website": {
    "market": "SE",
    "state": "not_on_record"
   }
  },
  "licensed": {
   "columns": [
    "licensor",
    "entitlement",
    "title",
    "date",
    "source"
   ],
   "rows": [],
   "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded."
  },
  "lifecycle": {
   "delisting": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "domicile_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "listing": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "name_change": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   },
   "segment_move": {
    "market": "SE",
    "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)",
    "state": "not_on_record"
   }
  },
  "market": "SE",
  "node": "se-cm-kg",
  "numbers_hash": "sha256:21f70d6b5796ab167ff6e732d037a00db20870ccdb5280f33de17da7304b9851",
  "open_research": {
   "read_date": "2026-11-12",
   "rows": [],
   "state": "none_found"
  },
  "orderability": {
   "chapter_as_of": "2026-11-04",
   "client_categories": [],
   "determinable": false,
   "read": {
    "chapter": "https://se.eu-cm-kg.ai/book/aio.json",
    "door": "https://se.eu-cm-kg.ai/mcp",
    "tool": "get_orderability"
   },
   "reason": "the chapter's orderability section carries no client_categories: the outcome cannot name its client category",
   "rule_version": "acm-68000/se/mifid-ii-product-governance/r1",
   "section": "se.aio.v5"
  },
  "record": {
   "as_of": "2026-11-06",
   "url": "https://mcp.se-cm-kg.ai/record/XSTO/SE0015244520",
   "version": 1
  },
  "schema": "research-numbers v0.1 (USR-01, 2026-11-11)",
  "status": {
   "read_date": "2026-11-09",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation",
   "value": "listed, not halted"
  }
 },
 "numbers_hash": "sha256:21f70d6b5796ab167ff6e732d037a00db20870ccdb5280f33de17da7304b9851",
 "path": "/se/XSTO/SE0015244520",
 "schema": "research-page v0.1 (USR-02, 2026-11-11)",
 "sections": [
  {
   "id": "identity",
   "text": "The issuer is BioInvent International AB, listed on Nasdaq Stockholm under the ticker SE0015244520 with ISIN SE0015244520 and LEI 549300E7QRHEF2IJUY10. The security type, segment, sector and jurisdiction are not on the record. The listing status is listed, not halted.",
   "title": "Identity and listing"
  },
  {
   "id": "disclosure",
   "text": "The record holds 39 filings in the twelve months to 2026-11-06, on 32 filing days. The median gap between filing days is 8 days. The latest filing is 1 day before the record date, and its date is 2026-11-05, of type Inside information. The exchange median gap between filing days is 9.5 days, the exchange median is 30.0 filings and the exchange median latency is 7.0 days, across 398 issuers on Nasdaq Stockholm. The sector comparison is not on the record.",
   "title": "The disclosure read"
  },
  {
   "id": "auditor",
   "text": "The auditor of record is not on the record, and neither is its location. The market's record does not carry auditor changes.",
   "title": "Auditor"
  },
  {
   "id": "events",
   "text": "The record carries no listing, delisting, name change, domicile change or segment move lines, because the lifecycle type map for this market is not yet on the register. The issuer is listed, not halted.",
   "title": "Events and halts"
  },
  {
   "id": "orderability",
   "text": "The outcome is not determinable for this issuer. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/se/mifid-ii-product-governance/r1, and the chapter is as of 2026-11-04.",
   "title": "Orderability"
  },
  {
   "id": "coverage",
   "text": "The issuer's investor-relations page names 4 research houses: Pareto Securities, Zurich; Kempen, Amsterdam; Redeye, Stockholm; and DNB Carnegie, Stockholm.",
   "title": "Coverage"
  },
  {
   "id": "open_research",
   "text": "No openly published research notes were found on the record.",
   "title": "Open research"
  },
  {
   "id": "licensed",
   "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.",
   "title": "Licensed"
  },
  {
   "id": "depth",
   "text": "The market's vintage is not sealed. No sealed years hold the issuer, no earliest sealed date is given for the market, and the live record began on no date given.",
   "title": "As-of depth"
  },
  {
   "id": "sources",
   "text": "7 source pages are named on this page; every value above carries its own source page and read date in the numbers.",
   "title": "Sources"
  }
 ],
 "sources": [
  {
   "for": "identity.exchange",
   "source": "https://firds.esma.europa.eu/firds/"
  },
  {
   "for": "identity.lei",
   "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download"
  },
  {
   "for": "the disclosure lines",
   "source": "https://mcp.se-cm-kg.ai/events/XSTO/SE0015244520"
  },
  {
   "for": "the halt flag",
   "source": "https://api.news.eu.nasdaq.com/news/query.action?globalGroup=exchangeNotice&globalName=ExchangenewsFilter|FirstNorthInformation"
  },
  {
   "for": "the orderability chapter",
   "source": "https://se.eu-cm-kg.ai/book/aio.json"
  },
  {
   "for": "coverage",
   "source": "https://www.bioinvent.com/en/investors/analysts"
  },
  {
   "for": "the record",
   "source": "https://mcp.se-cm-kg.ai/record/XSTO/SE0015244520"
  }
 ],
 "title": "BioInvent International AB (SE0015244520) — research page",
 "writer": {
  "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers",
  "engine": "claude-haiku-5-5"
 }
}